Secondary malignant neoplasm of unspecified kidney and renal pelvis
ICD-10 C79.00 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of unspecified kidney and renal pelvis.
C79.00 refers to secondary malignant neoplasms that have metastasized to the kidney and renal pelvis from an unknown primary site. This condition indicates that cancer cells from another part of the body have spread to the kidneys, which can occur in various malignancies, including lung, breast, and colorectal cancers. The kidneys may not exhibit specific symptoms until the disease is advanced, making early detection challenging. Patients may present with nonspecific symptoms such as hematuria, flank pain, or renal dysfunction. Staging of metastatic disease is crucial for treatment planning and prognosis, often utilizing imaging studies like CT scans or MRIs to assess the extent of metastasis. Palliative care considerations are essential, focusing on symptom management and quality of life, especially in advanced stages where curative treatment may not be feasible. Understanding the patient's overall health status and preferences is vital in guiding treatment decisions and supportive care.
Detailed history of the primary cancer, staging information, and treatment plans.
Patients with known malignancies presenting with renal symptoms.
Ensure clear documentation of metastasis and any treatments administered.
Urological evaluations, imaging results, and renal function tests.
Patients with renal masses or unexplained renal symptoms.
Differentiate between primary renal tumors and secondary involvement.
Used when a biopsy confirms metastatic disease in the kidney.
Pathology report must be included.
Oncology and pathology must coordinate documentation.
C79.00 is crucial for accurately representing secondary malignancies in the kidney, which impacts treatment decisions and patient management. Proper coding ensures that patients receive appropriate care and that healthcare providers are reimbursed correctly.
